A

Atara Biotherapeutics

D
ATRA
USD
0.075
(0.75%)
Market Closed
3,517.00
Volume
-18.065
EPS
-
Div Yield
-0.258333
P/E
57,165,036.18
Market Cap
Today
0.7500%
1 Week
13.075%
1 Month
29.832%
6 Months
-33.289%
12 Months
-69.470%
Year To Date
-21.427%
All Time
-53.074%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
B
BMRN
0.785
(1.1869%)
USD
I
INCY
1.47
(1.8173%)
USD
A
ARRY
0.25
(4.223%)
USD
L
LGND
18.7
(16.8408%)
USD
M
MRTX
(%)
USD
C
CRSP
1.04
(2.0444%)
USD
E
EDIT
-0.11
(-3.3537%)
USD
B
BLUE
-0.0615
(-14.0764%)
USD

Title:
Atara Biotherapeutics Inc.

Sector:
Healthcare
Industry:
Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Do you need help or have a question?
Contact Us